iShares US Pharmaceuticals ETF
IHE
IHE
92 hedge funds and large institutions have $60.8M invested in iShares US Pharmaceuticals ETF in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 32 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
less funds holding
Funds holding: →
less ownership
Funds ownership: →
31% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 32
37% less capital invested
Capital invested by funds: $96.2M → $60.8M (-$35.4M)
Holders
92
Holding in Top 10
–
Calls
$1.14M
Puts
$800K
Top Buyers
| 1 | +$3.05M | |
| 2 | +$2.64M | |
| 3 | +$1.46M | |
| 4 |
CG
Cutler Group
San Francisco,
California
|
+$424K |
| 5 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
+$281K |
Top Sellers
| 1 | -$15.1M | |
| 2 | -$5.4M | |
| 3 | -$3.29M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$2.45M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$1.18M |